
11 - 50 employees
Founded 1997
𧬠Biotechnology
π₯ Healthcare
π Pharmaceuticals
Biotechnology β’ Healthcare β’ Pharmaceuticals
Altimmune is a late-stage clinical biopharmaceutical company focused on developing therapies for serious liver diseases. The companyβs pipeline targets conditions with high unmet need including metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD), and alcohol-associated liver disease (ALD). Its lead candidate, pemvidutide, is an investigational therapy designed to address liver disease via glucagon receptor activity and metabolic effects through GLP-1 activity. Altimmune advances treatments by addressing fundamental mechanisms driving liver disease progression.
π₯ 2 hours ago
Director of Regulatory Affairs at Altimmune responsible for global CMC support. Managing regulatory submissions, compliance, and project timelines in biopharmaceutical development.